Suppr超能文献

非对称-苄基双吡啶醇酰胺的合成及其对SARS-CoV-2病毒主要蛋白酶的抑制活性研究

Synthesis of non-symmetric -benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus.

作者信息

Dalinger A I, Baev D S, Yarovaya O I, Chirkova V Yu, Sharlaeva E A, Belenkaya S V, Shcherbakov D N, Salakhutdinov N F, Vatsadze S Z

机构信息

Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119991 Moscow, Russian Federation.

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 prosp. Acad. Lavrentieva, 630090 Novosibirsk, Russian Federation.

出版信息

Russ Chem Bull. 2023;72(1):239-247. doi: 10.1007/s11172-023-3729-x. Epub 2023 Feb 14.

Abstract

Based on the data obtained by molecular modeling of the non-covalent interaction of non-symmetric -benzylbispidin-9-ol amides with the active site of the main protease 3CLpro of the SARS-CoV-2 virus, a series of compounds was synthesized, and their inhibitory activity against 3CLpro was studied and compared with that of the known inhibitor ML188 (IC = 1.56±0.55 µmol L). It was found that only compound containing the 1,4-dihydroindeno[1,2-]pyrazole fragment showed moderate activity (IC = 100±5.7µmol L) and was characterized by the highest calculated binding energy among the studied bispidine derivatives according to molecular docking data.

摘要

基于对非对称苄基双吡啶-9-醇酰胺与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒主要蛋白酶3CLpro活性位点非共价相互作用进行分子建模所获得的数据,合成了一系列化合物,并研究了它们对3CLpro的抑制活性,并与已知抑制剂ML188(IC = 1.56±0.55 µmol/L)的抑制活性进行了比较。结果发现,只有含有1,4-二氢茚并[1,2-b]吡唑片段的化合物表现出中等活性(IC = 100±5.7µmol/L),并且根据分子对接数据,在所研究的双吡啶衍生物中,该化合物具有最高的计算结合能。

相似文献

2
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.PGG 和 EGCG 对 SARS-CoV-2 3CL 样蛋白酶的抑制作用。
Biochem Biophys Res Commun. 2022 Feb 5;591:130-136. doi: 10.1016/j.bbrc.2020.12.106. Epub 2021 Jan 6.
7
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors.基于联吡啶的新型冠状病毒2型主要蛋白酶抑制剂的设计与评估
ACS Med Chem Lett. 2021 Sep 29;13(1):140-147. doi: 10.1021/acsmedchemlett.1c00299. eCollection 2022 Jan 13.

本文引用的文献

1
Yes SIR! On the structure-inactivity relationships in drug discovery.是的,先生!关于药物发现中的构效关系。
Drug Discov Today. 2022 Aug;27(8):2353-2362. doi: 10.1016/j.drudis.2022.05.005. Epub 2022 May 11.
2
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors.基于联吡啶的新型冠状病毒2型主要蛋白酶抑制剂的设计与评估
ACS Med Chem Lett. 2021 Sep 29;13(1):140-147. doi: 10.1021/acsmedchemlett.1c00299. eCollection 2022 Jan 13.
9
Copper-Bispidine Complexes: Synthesis and Complex Stability Study.铜-联吡啶配合物:合成与配合物稳定性研究
ACS Omega. 2016 Nov 8;1(5):854-867. doi: 10.1021/acsomega.6b00237. eCollection 2016 Nov 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验